Chemical Overview
Anastrozole is a non-steroidal aromatase inhibitor extensively researched for its potent inhibition of the CYP19A1 enzyme. Laboratory studies investigate this compound’s mechanism as a competitive antagonist that reversibly binds to the aromatase active site, preventing the conversion of androgens to estrogens. Researchers at Stroid UK Shop examine Beligas Pharma’s pharmaceutical-grade formulation, which provides precise 1mg dosing for controlled experimental protocols. This compound serves as a critical tool in endocrinology research, particularly in studies examining estrogen-dependent pathways and hormonal feedback mechanisms in cellular and tissue models.
Laboratory Applications
Research laboratories utilise anastrozole to investigate aromatase enzyme kinetics and estrogen biosynthesis pathways. Scientists examine its IC50 values, binding affinity characteristics, and selectivity profiles compared to other enzyme inhibitors. The compound’s oral bioavailability and pharmacokinetic properties make it valuable for researchers studying hormone-dependent cell lines and tissue cultures. Investigators explore its effects on estrogen-sensitive pathways in breast cancer cell research, bone metabolism studies, and reproductive endocrinology experiments. Academic institutions reference this compound when developing novel aromatase inhibitors or studying estrogen receptor modulation. Researchers specialising in aromatase inhibitors utilise it as a standard comparator in enzymatic assays and molecular biology applications.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Anastrozole |
| CAS Number | 120511-73-1 |
| Molecular Formula | C₁₇H₁₉N₅ |
| Molecular Weight | 293.37 g/mol |
| Concentration | 1mg per tablet |
| Quantity | 50 tablets |
| Manufacturer | Beligas Pharma |
| Storage | Room temperature, dry |
Laboratories conducting comparative studies often reference compounds available in SARMS and peptides categories when designing comprehensive hormonal research protocols.
Research Compliance
This anastrozole formulation is supplied strictly for in-vitro laboratory research applications. Researchers must maintain proper documentation, follow institutional protocols, and ensure appropriate safety measures when handling this compound. Academic and commercial laboratories should verify all regulatory requirements before commencing research protocols. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments.
